{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:00:26Z","timestamp":1789880426175,"version":"4.0.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Plan Nacional de Investigaci\u00f3n","award":["SAF2011-30528"],"award-info":[{"award-number":["SAF2011-30528"]}]},{"DOI":"10.13039\/501100003529","name":"European Union","doi-asserted-by":"publisher","award":["FP7-HEALTH-2007-B-2.3.4-1.223048"],"award-info":[{"award-number":["FP7-HEALTH-2007-B-2.3.4-1.223048"]}],"id":[{"id":"10.13039\/501100003529","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Instituto de Salud Carlos III, Spain","award":["FIS 11\/02571"],"award-info":[{"award-number":["FIS 11\/02571"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jconrel.2014.11.002","type":"journal-article","created":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T03:17:16Z","timestamp":1415589436000},"page":"190-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"C","title":["Nanobody conjugated PLGA nanoparticles for active targeting of African Trypanosomiasis"],"prefix":"10.1016","volume":"197","author":[{"given":"Jos\u00e9 L.","family":"Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan D.","family":"Unciti-Broceta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Maceira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Hern\u00e1ndez-Quero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Magez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Garc\u00eda-Salcedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2014.11.002_bb0005","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(03)14694-6","article-title":"The trypanosomiases","volume":"362","author":"Barrett","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.idc.2012.03.003","article-title":"Human African trypanosomiasis","volume":"26","author":"Brun","year":"2012","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human African trypanosomiasis","volume":"375","author":"Brun","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0020","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0140-6736(98)00416-4","article-title":"The fall and rise of sleeping sickness","volume":"353","author":"Barrett","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0025","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(06)68591-7","article-title":"The rise and fall of sleeping sickness","volume":"367","author":"Barrett","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0030","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.mib.2010.08.009","article-title":"Molecular mechanisms underlying the control of antigenic variation in African trypanosomes","volume":"13","author":"Horn","year":"2010","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/bse0510047","article-title":"African trypanosomes: the genome and adaptations for immune evasion","volume":"51","author":"Rudenko","year":"2011","journal-title":"Essays Biochem."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2958.2004.04224.x","article-title":"Endocytosis, membrane recycling and sorting of GPI-anchored proteins: Trypanosoma brucei as a model system","volume":"53","author":"Overath","year":"2004","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0166-6851(97)00191-6","article-title":"Both IgM and IgG anti-VSG antibodies initiate a cycle of aggregation-disaggregation of bloodstream forms of Trypanosoma brucei without damage to the parasite","volume":"91","author":"O'Beirne","year":"1998","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0050","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.cell.2007.08.046","article-title":"Hydrodynamic flow-mediated protein sorting on the cell surface of trypanosomes","volume":"131","author":"Engstler","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0092-8674(94)90574-6","article-title":"A novel heterodimeric transferrin receptor encoded by a pair of VSG expression site-associated genes in T. brucei","volume":"78","author":"Salmon","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0060","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1083\/jcb.131.5.1173","article-title":"Transferrin-binding protein complex is the receptor for transferrin uptake in Trypanosoma brucei","volume":"131","author":"Steverding","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0065","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2174\/138161207780162809","article-title":"Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting","volume":"13","author":"Luscher","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0070","series-title":"Trypanosomes and Trypanosomiasis","first-page":"217","article-title":"Progress towards new treatments for human African trypanosomiasis","author":"Garcia-Salcedo","year":"2014"},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2014.11.002_bb0075","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1007\/s00436-002-0769-2","article-title":"Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs","volume":"90","author":"Kayser","year":"2003","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0080","doi-asserted-by":"crossref","first-page":"8454","DOI":"10.1021\/nn2038252","article-title":"Reshaping the future of nanopharmaceuticals: ad iudicium","volume":"5","author":"Moghimi","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0085","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1002\/adma.201202080","article-title":"Materials for drug delivery: innovative solutions to address complex biological hurdles","volume":"24","author":"Mitragotri","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0090","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijpharm.2005.03.024","article-title":"Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers","volume":"298","author":"Beletsi","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/jbm.a.32247","article-title":"PEGylation strategies for active targeting of PLA\/PLGA nanoparticles","volume":"91","author":"Betancourt","year":"2009","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0105","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.actbio.2009.04.012","article-title":"Functionalized poly(lactic-co-glycolic acid) enhances drug delivery and provides chemical moieties for surface engineering while preserving biocompatibility","volume":"5","author":"Bertram","year":"2009","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","article-title":"The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems\u2014a review","volume":"415","author":"Fredenberg","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2007.10.030","article-title":"PLGA-based drug delivery systems: importance of the type of drug and device geometry","volume":"354","author":"Klose","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0065-2776(01)79006-2","article-title":"Functional heavy-chain antibodies in Camelidae","volume":"79","author":"Nguyen","year":"2001","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0968-0004(01)01790-X","article-title":"Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains","volume":"26","author":"Muyldermans","year":"2001","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0130","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1074\/jbc.M007734200","article-title":"Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs","volume":"276","author":"Els Conrath","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0135","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0161-5890(99)00067-X","article-title":"Loss of splice consensus signal is responsible for the removal of the entire C(H)1 domain of the functional camel IGG2A heavy-chain antibodies","volume":"36","author":"Nguyen","year":"1999","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0145","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0161-5890(97)00146-6","article-title":"Comparison of llama VH sequences from conventional and heavy chain antibodies","volume":"34","author":"Vu","year":"1997","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0150","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/protein\/7.9.1129","article-title":"Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains","volume":"7","author":"Muyldermans","year":"1994","journal-title":"Protein Eng."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0155","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.4155\/tde.13.87","article-title":"Novel therapy based on camelid nanobodies","volume":"4","author":"Unciti-Broceta","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0160","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.antiviral.2011.09.002","article-title":"Nanobodies(R): new ammunition to battle viruses","volume":"92","author":"Vanlandschoot","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2010.03.020","article-title":"Downregulation of EGFR by a novel multivalent nanobody-liposome platform","volume":"145","author":"Oliveira","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0170","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nm1395","article-title":"Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor","volume":"12","author":"Baral","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0175","doi-asserted-by":"crossref","first-page":"e40331","DOI":"10.1371\/journal.pone.0040331","article-title":"High-affinity target binding engineered via fusion of a single-domain antibody fragment with a ligand-tailored SH3 domain","volume":"7","author":"J\u00e4rviluoma","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.nbt.2012.09.002","article-title":"Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth","volume":"30","author":"Behdani","year":"2013","journal-title":"N. Biotechnol."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0185","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1021\/nn1023363","article-title":"Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy","volume":"5","author":"Van De Broek","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jconrel.2011.12.027","article-title":"Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment","volume":"159","author":"van der Meel","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2012.11.007","article-title":"Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells","volume":"165","author":"Altintas","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0200","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1007\/s00018-010-0387-6","article-title":"A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines","volume":"67","author":"Smolarek","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0205","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1074\/jbc.M307341200","article-title":"Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm","volume":"279","author":"Stijlemans","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0210","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1128\/AAC.45.10.2807-2812.2001","article-title":"Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae","volume":"45","author":"Conrath","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0215","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/S0142-9612(00)00115-0","article-title":"The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices","volume":"21","author":"Jain","year":"2000","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0220","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/02652048.2011.576786","article-title":"Insulin-loaded PLGA microparticles: flow focusing versus double emulsion\/solvent evaporation","volume":"28","author":"C\u00f3zar-Bernal","year":"2011","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-012-0768-x","article-title":"Maghemite\/poly(d,l-lactide-co-glycolyde) composite nanoplatform for therapeutic applications","volume":"14","author":"P\u00e9rez-Artacho","year":"2012","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0230","doi-asserted-by":"crossref","first-page":"10548","DOI":"10.1074\/jbc.M112.449207","article-title":"Nicotinamide inhibits the lysosomal cathepsin B-like protease and kills African trypanosomes","volume":"288","author":"Unciti-Broceta","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0235","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0960-9822(00)80018-4","article-title":"N-linked glycans containing linear poly-N-acetyllactosamine as sorting signals in endocytosis in Trypanosoma brucei","volume":"9","author":"Nolan","year":"1999","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0240","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrmicro2221","article-title":"The trypanosome flagellar pocket","volume":"7","author":"Field","year":"2009","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0245","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2012.05.042","article-title":"Challenges in design of translational nanocarriers","volume":"164","author":"Sun","year":"2012","journal-title":"J. Control. Release"},{"issue":"Supplement","key":"10.1016\/j.jconrel.2014.11.002_bb0250","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.addr.2012.09.008","article-title":"The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres","volume":"64","author":"Gref","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0255","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2005.02.025","article-title":"Stability of insulin during the erosion of poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres","volume":"106","author":"Ibrahim","year":"2005","journal-title":"J. Controlled Rel."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0260","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2174\/138945011795906606","article-title":"Possibilities of Poly(D,L-lactide-co-glycolide) in the formulation of nanomedicines against cancer","volume":"12","author":"Holgado","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jconrel.2014.11.002_bb0265","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpharm.2012.12.048","article-title":"Biocompatible gemcitabine-based nanomedicine engineered by Flow Focusing\u00ae for efficient antitumor activity","volume":"443","author":"Mart\u00edn-Banderas","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0270","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijpharm.2008.02.012","article-title":"Synthesis of lidocaine-loaded PLGA microparticles by flow focusing: Effects on drug loading and release properties","volume":"358","author":"Holgado","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0275","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2007.01.016","article-title":"Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo","volume":"119","author":"Mittal","year":"2007","journal-title":"J. Controlled Rel."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0280","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ijantimicag.2012.01.003","article-title":"In vitro evaluation of bisnaphthalimidopropyl derivatives loaded into pegylated nanoparticles against Leishmania infantum protozoa","volume":"39","author":"Costa Lima","year":"2012","journal-title":"Int. J. Antimicrob. Agents."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0285","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2011.08.016","article-title":"PLGA nanoparticles loaded with the antileishmanial saponin \u03b2-aescin: Factor influence study and in vitro efficacy evaluation","volume":"420","author":"Van de Ven","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0290","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.addr.2009.11.025","article-title":"Nanotechnological approaches against Chagas disease","volume":"62","author":"Romero","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0295","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.addr.2009.11.024","article-title":"Nanotechnology applied to the treatment of malaria","volume":"62","author":"Santos-Magalh\u00e3es","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.11.002_bb0300","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.actatropica.2008.07.006","article-title":"Efficacy of the diamidine DB75 and its prodrug DB289, against murine models of human African trypanosomiasis","volume":"108","author":"Thuita","year":"2008","journal-title":"Acta Trop."},{"key":"10.1016\/j.jconrel.2014.11.002_bb9005","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nature08893","article-title":"N-myristoyltransferase inhibitors as new leads to treat sleeping sickness","volume":"464","author":"Frearson","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2014.11.002_bb9010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1550-7408.1976.tb03787.x","article-title":"Pentamidine transport and sensitivity in brucei-group trypanosomes","volume":"23","author":"Damper","year":"1976","journal-title":"J. Protozool."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914007391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914007391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T14:51:02Z","timestamp":1572533462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365914007391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":62,"alternative-id":["S0168365914007391"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.11.002","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanobody conjugated PLGA nanoparticles for active targeting of African Trypanosomiasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}